Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi - Turkey
doi 10.4999/uhod.11012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Akademi Doktorlar Yayinevi


Related search